Court upholds disclosure order for off-patent drug finding newer patent applicable to the drug
The Federal Court has upheld a decision requiring a pharmaceutical company to disclose certain sales and financial information for an off-patent medication, finding another patent to be applicable to the medicine....To view the full article, register now.
Already a subscriber? Click here to view full article